Press releases

Here you can find corporate releases on topics related to governance, investments, and important announcements.

Read more

Investors

Nasdaq:

CRMD

$ 6.87 Last update: 01/24/2026 4:52:46 pm ET Time Read more

About CRBSI

Learn more about Catheter-related blood stream infections (CRBSIs) and how they affect hemodialysis central venous catheter (HD-CVC) patients.

Read more
WHY CORMEDIX

We relentlessly pursue therapeutic options to reduce and treat infectious and inflammatory disease

About us
PRESS RELEASES

Review corporate releases related to governance,
investor news, and other important announcements.

Jan 09, 2026

CORMEDIX THERAPEUTICS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Jan 08, 2026

CORMEDIX THERAPEUTICS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 RESULTS AND PROVIDES BUSINESS UPDATES

CORMEDIX THERAPEUTICS ANNOUNCES LEADERSHIP AND BOARD UPDATES
Dec 18, 2025

CORMEDIX THERAPEUTICS ANNOUNCES POSITIVE DATA FROM ONGOING REAL WORLD EVIDENCE STUDY OF DEFENCATH
Nov 12, 2025

CORMEDIX INC. REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND UPDATES FY 2025 GUIDANCE
See all